Clinical Trial Update: Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 long-term safety and tolerability study in approximately 350 adults with moderate to severe chronic non-malign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Snippet

Sponsor: Abbott | Conditions: Moderate to Severe Chronic, Non-malignant Pain | Phase 3 | Status: COMPLETED